Sera Prognostics (SERA) Change in Receivables (2020 - 2026)
Sera Prognostics (SERA) posted Change in Receivables of -$1000.0 for Q1 2026, up 50.0% on a QoQ basis from -$2000.0 in Q4 2025, and up 88.89% year-over-year from -$529.41 in Q1 2025.
Sera Prognostics (SERA) Change in Receivables (2020 - 2026) Analysis & Trends
Sera Prognostics' Change in Receivables history runs 7 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- Quarterly Change in Receivables rose 88.89% year-over-year to -$1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14000.0 (up 84.78% YoY) and the FY2025 annual result came in at -$22000.0, up 82.54% from the prior year.
- Change in Receivables was -$1000.0 for Q1 2026 at Sera Prognostics, up from -$2000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $43000.0 in Q2 2023 and bottomed at -$45000.0 in Q4 2024.
- A 5-year average of -$941.18 and a median of -$2000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables surged 466.67% — and 2024, when it slumped 1000.0%.
- Sera Prognostics' Change in Receivables stood at $6000.0 in 2022, then decreased by 16.67% to $5000.0 in 2023, then slumped by 1000.0% to -$45000.0 in 2024, then soared by 95.56% to -$2000.0 in 2025, then soared by 50.0% to -$1000.0 in 2026.
- Business Quant data shows SERA's Change in Receivables at -$1000.0 in Q1 2026, -$2000.0 in Q4 2025, and -$3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -124.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -141.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Sera Prognostics | 105.54 Mn | 105.54 Mn | -28,000.00 | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -45,000.00 |
| Dec 31, 2024 | -45,000.00 |
| Sep 30, 2024 | -22,000.00 |
| Sep 30, 2024 | -22,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |